We use cookies for a better user experience. Read our Privacy Policy

I Agree

Paralysis (Plegia) Treatment Market

Paralysis (Plegia) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Paralysis (Plegia) Treatment Market: Introduction

  • Plegia, or paralysis, is a paralysis of skeletal muscles. An incomplete paralysis is also known as a paresis. A plegia is generally caused by damage to one or more nerves that travel from the brain to the muscle and initiate movements. Nerves could disrupt along their course in the upper or lower motor neuron, i.e. in the spinal cord, in the brain, or in the body. Plegia could be classified by the location of damage or by the affected limb.
  • Depending on the location of nerve disruption, either in the lower or upper motor neuron, plegia is classified as central or peripheral. The lower motor neuron expands from the anterior horn cell of the spinal cord to the neuromuscular junction of the muscle. An injury in the lower motor neuron is also known as a peripheral plegia. Peripheral plegia usually affects one or more nerves (plexus paresis). The upper motor neuron usually runs from the brain to the anterior horn cell of the spinal cord. If damage occurs in the upper motor neuron of the nerve, it is known as central plegia. Paralyses are diagnosed by testing the muscle strength. The clinical diagnosis of muscle strength is carried out by assessments. The most common is the diagnosis with the help of the Medical Research Council (MRC), where 0 points represent a paralysis, i.e. plegia.
  • The paralysis (plegia) treatment market can be segmented based on type, end-user, and region. Based on type, the market can be categorized into physical therapy, occupational therapy, and assistive devices & medications. Meanwhile, the assistive devices segment can be further classified into walkers, wheelchairs, grab bars, specialized handles, and grips & voice-activated technology. Based on end-user, the market can be split into hospitals, specialty clinics, ambulatory surgical centers, homecare, & others.

Key Drivers, Restraints, and Opportunities of Global Paralysis (Plegia) Treatment Market

  • The shortage of physical activity and the adoption of an unhealthy lifestyle, collaborations & acquisitions by pharmaceuticals companies for the technological advancement of treatment are major factors driving the paralysis (plegia) treatment market
  • However, limited availability of treatment options owing to the lower prevalence of (plegia) paralysis and fewer approvals of drugs from regulatory authorities is estimated to hamper the market during the during forecast period
  • Increase in healthcare expenditure and substantial financial support to researchers for the development of novel interventions are projected to provide significant opportunity for the market

North America to Capture Major Share of Global Paralysis (Plegia) Treatment Market

In terms of region, North America is anticipated to dominate the global market during the forecast period. North America followed by Europe is projected to hold a major share of the paralysis (plegia) treatment market. Rise in sleep disorders, increase in awareness, and surge in R&D activity for chronic disorders are key factors that are estimated to drive the market in the region. Emerging economies such as China and India are developing pharmaceutical products and are expected to contribute majorly toward the expansion of the paralysis (plegia) treatment market in Asia Pacific.

Key Players Operating in Global Paralysis (Plegia) Treatment Market

The global paralysis (plegia) treatment market is highly fragmented, with the presence of various key players. A large number of manufacturers hold a major share in their respective regions. Major players operating in the global paralysis (plegia) treatment market are:

  • Strongbridge Biopharma plc
  • Sun Pharmaceutical Industries Ltd
  • Heritage
  • Mylan N.V.
  • Zydus Cadila
  • Alembic Pharmaceuticals Limited
  • Teva Pharmaceutical Industries Ltd
  • X-GEN Pharmaceuticals, Inc
  • Cyberonics, Inc.
  • Novartis AG
  • Astellas Pharma Inc.
  • Mallinckrodt
  • Stryker
  • Teleflex Incorporated
  • Acclarent, Inc. (Johnson & Johnson)
  • Medtronic

Global Paralysis (PLEGIA) Treatment Market: Research Scope

Global Paralysis (PLEGIA) Treatment Market, by Type

  • Physical therapy
  • Occupational therapy
  • Assistive devices
    • Walkers
    • Wheelchairs
    • Grab bars
    • Specialized handles and grips
    • Voice-activated technology
  • Medications
    • Antimicrobials
    • Corticosteroids
  • Others

Global Paralysis (PLEGIA) Treatment Market, by End Users

  • Hospitals
  • Specialty clinics
  • Ambulatory surgical centers
  • Homecare
  • Others

Global Paralysis (PLEGIA) Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East &Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes


Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.


Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved